JP2005506959A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506959A5
JP2005506959A5 JP2003503665A JP2003503665A JP2005506959A5 JP 2005506959 A5 JP2005506959 A5 JP 2005506959A5 JP 2003503665 A JP2003503665 A JP 2003503665A JP 2003503665 A JP2003503665 A JP 2003503665A JP 2005506959 A5 JP2005506959 A5 JP 2005506959A5
Authority
JP
Japan
Prior art keywords
animals
administration
animal
day
corresponds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003503665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506959A (ja
JP4570355B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/006456 external-priority patent/WO2002100899A2/de
Publication of JP2005506959A publication Critical patent/JP2005506959A/ja
Publication of JP2005506959A5 publication Critical patent/JP2005506959A5/ja
Application granted granted Critical
Publication of JP4570355B2 publication Critical patent/JP4570355B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003503665A 2001-06-13 2002-06-12 腫瘍およびその転移の治療のための医薬 Expired - Lifetime JP4570355B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01114388 2001-06-13
DE10128639 2001-06-15
PCT/EP2002/006456 WO2002100899A2 (de) 2001-06-13 2002-06-12 Arzneimittel zur behandlung von tumoren und deren metastasen unter verwendung eines bindemoleküls gegen das bone-sialoprotein

Publications (3)

Publication Number Publication Date
JP2005506959A JP2005506959A (ja) 2005-03-10
JP2005506959A5 true JP2005506959A5 (https=) 2008-11-27
JP4570355B2 JP4570355B2 (ja) 2010-10-27

Family

ID=26009516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003503665A Expired - Lifetime JP4570355B2 (ja) 2001-06-13 2002-06-12 腫瘍およびその転移の治療のための医薬

Country Status (10)

Country Link
US (2) US7825219B2 (https=)
EP (1) EP1399186B1 (https=)
JP (1) JP4570355B2 (https=)
AT (1) ATE448796T1 (https=)
AU (1) AU2002319223A1 (https=)
DE (1) DE50214008D1 (https=)
DK (1) DK1399186T3 (https=)
ES (1) ES2336770T3 (https=)
PT (1) PT1399186E (https=)
WO (1) WO2002100899A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1514929A1 (en) * 2003-09-12 2005-03-16 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Antisense oligonucleotides for prevention of metastasis formation of cancer cells
US8282943B2 (en) 2005-05-31 2012-10-09 Ralf Jochem Therapeutic composition for use in the prevention and treatment of bone metastases
EP1931994A2 (en) * 2005-09-26 2008-06-18 Novartis AG Molecular markers associated with bone metastasis
RU2011111725A (ru) * 2008-08-29 2012-10-10 Симфоген А/С (Dk) Способ клонирования антител птиц
EP3182995B1 (en) 2014-08-19 2019-11-27 Immundiagnostik AG Medicament and apparatus for treating chronic kidney disease
EP4373522A4 (en) * 2021-07-20 2025-06-18 William Marsh Rice University Engineered compositions for bone-targeted therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853219A (en) * 1987-08-06 1989-08-01 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
AU769185B2 (en) * 1999-04-09 2004-01-15 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Complex formed by N-linked glycoproteins (siblings) and factor H

Similar Documents

Publication Publication Date Title
JP2009526751A5 (https=)
JP2005537234A5 (https=)
EP2292264A3 (en) Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
NZ542866A (en) Compositions and methods for the therapy of inflammatory bowel disease
JP2005506959A5 (https=)
JP2005523891A5 (https=)
JP2005501108A5 (https=)
WO2005087255A3 (en) Method of optimizing treatment with interferon-tau
RU99107254A (ru) Способ реабилитации больных с заболеванием почек
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.
RU2002108764A (ru) Способ лечения заболеваний желудочно-кишечного тракта телят
WO2005028608A3 (de) Zellprozessor zur krankheitsbehandlung
WO2006045313A3 (en) Uses of secretagogues for treatment of organ transplant patients
RU2003112906A (ru) Способ лечения акантолической пузырчатки
RU2002130727A (ru) Способ лечения детей и подростков с латентной туберкулезной инфекцией
RU2002112883A (ru) Способ повышения продуктивности и резистентности новотельных коров
RU96117561A (ru) Способ лечения токсикомании
RU2002112882A (ru) Способ повышения резистентности сухостойных коров
RU2003125149A (ru) Препарат для лечения гемобартонеллеза кошек, и способ его применения
RU2004123182A (ru) Способ лечения и профилактики нематодов поросят
RU2002104308A (ru) Способ лечения больных псориазом в сочетании с хроническим описторхозом в резидуальном периоде
Lazhentseva et al. Microflora of white whales during adaptation in Vladivostok dolphinarium.
RU2006113234A (ru) Способ комплексной активизации деятельности защитных приспособлений организма животного
RU2004119373A (ru) Способ восстановления вилочковой железы (тимуса) у людей зрелого и пожилого возрастов
RU2003110967A (ru) Способ применения этидия бромистого для лечения пироплазмоза лошадей